GLPG
Price
$24.01
Change
+$0.23 (+0.97%)
Updated
Apr 11 closing price
Capitalization
1.54B
11 days until earnings call
INZY
Price
$0.89
Change
+$0.01 (+1.14%)
Updated
Apr 11 closing price
Capitalization
56.92M
31 days until earnings call
Ad is loading...

GLPG vs INZY

Header iconGLPG vs INZY Comparison
Open Charts GLPG vs INZYBanner chart's image
Galapagos
Price$24.01
Change+$0.23 (+0.97%)
Volume$706.83K
Capitalization1.54B
Inozyme Pharma
Price$0.89
Change+$0.01 (+1.14%)
Volume$513.36K
Capitalization56.92M
GLPG vs INZY Comparison Chart
Loading...
GLPG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLPG vs. INZY commentary
Apr 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLPG is a Hold and INZY is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 12, 2025
Stock price -- (GLPG: $24.01 vs. INZY: $0.89)
Brand notoriety: GLPG and INZY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLPG: 284% vs. INZY: 96%
Market capitalization -- GLPG: $1.54B vs. INZY: $56.92M
GLPG [@Biotechnology] is valued at $1.54B. INZY’s [@Biotechnology] market capitalization is $56.92M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.66B to $0. The average market capitalization across the [@Biotechnology] industry is $1.98B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLPG’s FA Score shows that 0 FA rating(s) are green whileINZY’s FA Score has 1 green FA rating(s).

  • GLPG’s FA Score: 0 green, 5 red.
  • INZY’s FA Score: 1 green, 4 red.
According to our system of comparison, both GLPG and INZY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLPG’s TA Score shows that 4 TA indicator(s) are bullish while INZY’s TA Score has 4 bullish TA indicator(s).

  • GLPG’s TA Score: 4 bullish, 6 bearish.
  • INZY’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, INZY is a better buy in the short-term than GLPG.

Price Growth

GLPG (@Biotechnology) experienced а +1.09% price change this week, while INZY (@Biotechnology) price change was +7.90% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.15%. For the same industry, the average monthly price growth was -16.20%, and the average quarterly price growth was -17.21%.

Reported Earning Dates

GLPG is expected to report earnings on Jul 23, 2025.

INZY is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+0.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLPG($1.54B) has a higher market cap than INZY($56.9M). GLPG YTD gains are higher at: -12.691 vs. INZY (-68.011). GLPG has higher annual earnings (EBITDA): -63.34M vs. INZY (-95.72M). GLPG has more cash in the bank: 3.34B vs. INZY (113M). GLPG has less debt than INZY: GLPG (11.5M) vs INZY (46.9M). GLPG has higher revenues than INZY: GLPG (260M) vs INZY (0).
GLPGINZYGLPG / INZY
Capitalization1.54B56.9M2,701%
EBITDA-63.34M-95.72M66%
Gain YTD-12.691-68.01119%
P/E Ratio53.70N/A-
Revenue260M0-
Total Cash3.34B113M2,955%
Total Debt11.5M46.9M25%
FUNDAMENTALS RATINGS
GLPG: Fundamental Ratings
GLPG
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
78
PRICE GROWTH RATING
1..100
75
P/E GROWTH RATING
1..100
49
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLPGINZY
RSI
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
75%
N/A
MACD
ODDS (%)
Bearish Trend 4 days ago
86%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
61%
Bullish Trend 20 days ago
86%
Declines
ODDS (%)
Bearish Trend 6 days ago
78%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
56%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
GLPG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRTX484.228.73
+1.84%
Vertex Pharmaceuticals
BEP21.35-0.02
-0.09%
Brookfield Renewable Partners LP
BBU20.20-0.38
-1.85%
Brookfield Business Partners LPLimited Partnership Units
CVRX6.23-0.25
-3.86%
CVRx
CRWS2.92-0.13
-4.27%
Crown Crafts

GLPG and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLPG has been loosely correlated with VCYT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if GLPG jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLPG
1D Price
Change %
GLPG100%
+0.97%
VCYT - GLPG
43%
Loosely correlated
+5.12%
INZY - GLPG
42%
Loosely correlated
+0.61%
NTLA - GLPG
38%
Loosely correlated
+9.45%
RGNX - GLPG
37%
Loosely correlated
+8.87%
BEAM - GLPG
37%
Loosely correlated
+5.74%
More

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with IGMS. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then IGMS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
+0.61%
IGMS - INZY
53%
Loosely correlated
+13.21%
MRSN - INZY
50%
Loosely correlated
+18.94%
CRNX - INZY
48%
Loosely correlated
+8.42%
ERAS - INZY
48%
Loosely correlated
+16.43%
THRD - INZY
47%
Loosely correlated
+4.90%
More